Please login to the form below

Not currently logged in
Email:
Password:

Management team buys out Wells Healthcare and Quantum Medical

An internal management team has initiated a majority buy-out of Interlace Global, the holding company for Wells Healthcare and Quantum Medical Communications

An internal management team of UK-based global medical communications agency, Interlace Global, has initiated a majority buy-out of Interlace Global, which is the holding company for both medical communications company, Wells Healthcare, and regulatory and pharmacovigilance medical writing agency, Quantum Medical Communications.

Wells and Quantum provide pharmaceutical communications for clients requiring science, increased senior counsel and strategic publication planning or developing relationships with key opinion leaders. Other services are a thorough understanding of the requirements of pharmacovigilance, risk management and regulatory strategy before launch.

Two senior members of the management team have taken a majority shareholding and have joined the board: Mark Forbes Irving, as managing director, and Vanita Buxton, as finance director. Andrew Wright, former majority shareholder and Chairman of both companies, will continue as a director.

Andrew Wright said of the buy out: "I am very pleased to take this major step for the business after 25 years of family ownership. Mark and Vanita have won my confidence over the past few years. By extending both the ownership and management of Wells Healthcare and Quantum Medical, I believe the business will continue to grow and provide exceptional client delivery. The benefits to clients are absolute continuity, enhanced management direction and sustained high levels of service."

Forbes Irving, managing director, added: "Interlace Global is a powerhouse of understanding and delivery and is one of the premier independent global communications groups. As such, it is uniquely placed to deliver excellence in integrated healthcare communications."

Wells has a staff of 33 people, with three more senior appointments to be announced in due course. Quantum's team comprises ten full-time members and is also currently expanding its in-house capabilities. Clients across both companies include the majority of the top 25 global research based pharmaceutical companies.

5th April 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics